168 related articles for article (PubMed ID: 26138841)
61. Osteogenesis Imperfecta: A Pediatric Orthopedic Perspective.
Franzone JM; Shah SA; Wallace MJ; Kruse RW
Orthop Clin North Am; 2019 Apr; 50(2):193-209. PubMed ID: 30850078
[TBL] [Abstract][Full Text] [Related]
62. Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children.
Galindo-Zavala R; Bou-Torrent R; Magallares-López B; Mir-Perelló C; Palmou-Fontana N; Sevilla-Pérez B; Medrano-San Ildefonso M; González-Fernández MI; Román-Pascual A; Alcañiz-Rodríguez P; Nieto-Gonzalez JC; López-Corbeto M; Graña-Gil J
Pediatr Rheumatol Online J; 2020 Feb; 18(1):20. PubMed ID: 32093703
[TBL] [Abstract][Full Text] [Related]
63. The use of bisphosphonates in children with osteogenesis imperfecta.
Glorieux FH
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1491-5. PubMed ID: 11837505
[TBL] [Abstract][Full Text] [Related]
64. [Lethal osteogenesis imperfecta. Prenatal diagnosis].
Dhouib M; Guirat N
Presse Med; 2004 Jun; 33(10):658-60. PubMed ID: 15257238
[TBL] [Abstract][Full Text] [Related]
65. Transient osteoporosis and osteogenesis imperfecta. A case report.
Noorda RJ; van der Aa JP; Wuisman PI; David EF; Lips PT; van der Valk P
Clin Orthop Relat Res; 1997 Apr; (337):249-55. PubMed ID: 9137196
[TBL] [Abstract][Full Text] [Related]
66. A comparative study of quality of life, functional and bone outcomes in osteogenesis imperfecta with bisphosphonate therapy initiated in childhood or adulthood.
Feehan AG; Zacharin MR; Lim AS; Simm PJ
Bone; 2018 Aug; 113():137-143. PubMed ID: 29787832
[TBL] [Abstract][Full Text] [Related]
67. Osteogenesis imperfecta.
Gertner JM; Root L
Orthop Clin North Am; 1990 Jan; 21(1):151-62. PubMed ID: 2296455
[TBL] [Abstract][Full Text] [Related]
68. [Osteogenesis imperfecta].
Schuh A; Hönle W; Effenberger H
MMW Fortschr Med; 2009 Nov; 151(48):38, 40. PubMed ID: 20085061
[No Abstract] [Full Text] [Related]
69. How should clinicians manage osteoporosis in ankylosing spondylitis?
Bessant R; Keat A
J Rheumatol; 2002 Jul; 29(7):1511-9. PubMed ID: 12136913
[TBL] [Abstract][Full Text] [Related]
70. Bisphosphonate use in conditions other than osteoporosis.
Silverman SL
Ann N Y Acad Sci; 2011 Feb; 1218():33-7. PubMed ID: 20946575
[TBL] [Abstract][Full Text] [Related]
71. Early bisphosphonate treatment in infants with severe osteogenesis imperfecta.
Antoniazzi F; Zamboni G; Lauriola S; Donadi L; Adami S; Tatò L
J Pediatr; 2006 Aug; 149(2):174-9. PubMed ID: 16887429
[TBL] [Abstract][Full Text] [Related]
72. Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures.
Angthong C; Rodjanawijitkul S; Samart S; Angthong W
Acta Orthop Traumatol Turc; 2013; 47(5):318-22. PubMed ID: 24164940
[TBL] [Abstract][Full Text] [Related]
73. Bisphosphonate therapy and osteogenesis imperfecta: The lived experience of children and their mothers.
Wiggins S; Kreikemeier R
J Spec Pediatr Nurs; 2017 Oct; 22(4):. PubMed ID: 28876506
[TBL] [Abstract][Full Text] [Related]
74. Osteoporosis disease management for fragility fracture patients: new understandings based on three years' experience with an osteoporosis care service.
Harrington JT; Lease J
Arthritis Rheum; 2007 Dec; 57(8):1502-6. PubMed ID: 18050169
[TBL] [Abstract][Full Text] [Related]
75. Fractures on bisphosphonates in osteoporosis pseudoglioma syndrome (OPPG): pQCT shows poor bone density and structure.
Streeten EA; Ramirez S; Eliades M; Jaimungal S; Chandrasekaran S; Kathleen R; Holmes Morton D; Puffenberger EG; Herskovitz R; Leonard MB
Bone; 2015 Aug; 77():17-23. PubMed ID: 25892485
[TBL] [Abstract][Full Text] [Related]
76. [Rare bone disorders and respective treatments].
Seefried L; Jakob F
Internist (Berl); 2021 May; 62(5):486-495. PubMed ID: 33779789
[TBL] [Abstract][Full Text] [Related]
77. Osteogenesis imperfecta: care and management.
Silverwood B
Paediatr Nurs; 2001 Apr; 13(3):38-42. PubMed ID: 12025296
[No Abstract] [Full Text] [Related]
78. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
Palomo T; Fassier F; Ouellet J; Sato A; Montpetit K; Glorieux FH; Rauch F
J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
[TBL] [Abstract][Full Text] [Related]
79. Osteogenesis imperfecta: an expanding panorama of variants.
Sillence D
Clin Orthop Relat Res; 1981 Sep; (159):11-25. PubMed ID: 7285446
[TBL] [Abstract][Full Text] [Related]
80. Long-term follow-up in osteogenesis imperfecta type VI.
Trejo P; Palomo T; Montpetit K; Fassier F; Sato A; Glorieux FH; Rauch F
Osteoporos Int; 2017 Oct; 28(10):2975-2983. PubMed ID: 28689307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
